Member News | The PHOENIX group has completed the acquisition of parts of McKesson Europe
November 16, 2022
PHOENIX group completes largest acquisition in company’s history
The PHOENIX group has completed the acquisition of parts of McKesson Europe, following the clearance by competition authorities of the full scope of the transaction.
The closing took place on 31 October 2022. The transaction includes the McKesson companies in Belgium, France, Ireland, Italy, Portugal, and Slovenia, as well as a shared service centre in Lithuania, German company recucare GmbH, McKesson’s European head office in Stuttgart and the minority stake in the Brocacef Groep joint venture in the Netherlands.
Following the acquisition, the healthcare provider now has a presence in 29 countries, more than 45,000 employees, 224 sites in the business areas pharmaceutical wholesale and pre-wholesale, as well as more than 3,200 own pharmacies and 17,000 partner pharmacies.
Thereby, the PHOENIX group is expanding its position as Europe’s leading pharmaceutical wholesaler, pharmacy operator, and service provider for the pharmaceutical industry.
For the time being, the healthcare provider will continue to operate the brands established locally by McKesson Europe in the pharmaceutical wholesale and pharmacy retail business. Thanks to the combined expertise of both companies, all customer groups will benefit from additional products and services in accordance with their local needs.
More info on Phoenix Group’s website
McKesson Corporation, we’re an impact-driven healthcare organization dedicated to “Advancing Health Outcomes For All.” As a global healthcare company, we touch virtually every aspect of health. We work with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services that make quality care more accessible and affordable.